Oracain Overview

  • Founded
  • 2011
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 2
Employees
  • Latest Deal Type
  • M&A

Oracain General Information

Description

Developer of oral pain medications designed to offer treatment for oral mucositis and other conditions related to oral diseases. The company's medications are based on known active compounds, reformulated to suit the present medical need in a range of indications, enabling patients to get advanced treatment and recover faster.

Contact Information

Website
www.oracain.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Acquirer
Primary Office
  • Diplomvej 381
  • 2800 Lyngby
  • Denmark
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Oracain Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 14-Apr-2014 Completed Startup
2. Early Stage VC (Series A) 01-Aug-2011 Completed Startup
1. Seed Round 01-Jan-2011 Completed Startup
To view Oracain’s complete valuation and funding history, request access »

Oracain Board Members (3)

Name Representing Role Since
Peter Nordkild MD Self Board Member 000 0000
You’re viewing 1 of 3 board members. Get the full list »

Oracain Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Oracain Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
PreSeed Ventures Venture Capital Minority 000 0000 000000 0
Seed Capital (Denmark) Venture Capital Minority 000 0000 000000 0
To view Oracain’s complete investors history, request access »